97 related articles for article (PubMed ID: 9029554)
1. Development of a new method for the analysis of sphinganine and sphingosine in urine and tissues.
Castegnaro M; Garren L; Gaucher I; Wild CP
Nat Toxins; 1996; 4(6):284-90. PubMed ID: 9029554
[TBL] [Abstract][Full Text] [Related]
2. Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1.
Qiu M; Liu X
Food Addit Contam; 2001 Mar; 18(3):263-9. PubMed ID: 11304035
[TBL] [Abstract][Full Text] [Related]
3. Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure.
Castegnaro M; Garren L; Galendo D; Gelderblom WC; Chelule P; Dutton MF; Wild CP
J Chromatogr B Biomed Sci Appl; 1998 Dec; 720(1-2):15-24. PubMed ID: 9892062
[TBL] [Abstract][Full Text] [Related]
4. The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisin B1.
Garren L; Galendo D; Wild CP; Castegnaro M
Food Addit Contam; 2001 Sep; 18(9):850-6. PubMed ID: 11552753
[TBL] [Abstract][Full Text] [Related]
5. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
[TBL] [Abstract][Full Text] [Related]
6. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
[TBL] [Abstract][Full Text] [Related]
7. Sphinganine and sphingosine levels and ratio in urine and blood samples from a Catalonian population, Spain.
Cano-Sancho G; Marin S; Sanchis V; Colom C; Coronel MB; Ramos AJ
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2011 Aug; 28(8):1055-65. PubMed ID: 21644119
[TBL] [Abstract][Full Text] [Related]
8. Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure.
Solfrizzo M; Avantaggiato G; Visconti A
J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):87-93. PubMed ID: 9187387
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic determination of sphinganine and sphingosine in serum and urine of subjects from an endemic nephropathy area in Croatia.
Ribar S; Mesarić M; Bauman M
J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):511-9. PubMed ID: 11339295
[TBL] [Abstract][Full Text] [Related]
10. Validation of urinary sphingolipid metabolites as biomarker of effect for fumonisins exposure in Kenyan children.
Wangia RN; Githanga DP; Xue KS; Tang L; Anzala OA; Wang JS
Biomarkers; 2019 Jun; 24(4):379-388. PubMed ID: 30821509
[No Abstract] [Full Text] [Related]
11. Sphinganine-sphingosine ratio in urine from two Portuguese populations as biomarker to fumonisins exposure.
Silva LJ; Lino CM; Pena A
Toxicon; 2009 Sep; 54(4):390-8. PubMed ID: 19477192
[TBL] [Abstract][Full Text] [Related]
12. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks.
Tardieu D; Tran ST; Auvergne A; Babilé R; Benard G; Bailly JD; Guerre P
Chem Biol Interact; 2006 Mar; 160(1):51-60. PubMed ID: 16412405
[TBL] [Abstract][Full Text] [Related]
13. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
[TBL] [Abstract][Full Text] [Related]
14. Effects of orally administered fumonisin B₁ (FB₁), partially hydrolysed FB₁, hydrolysed FB₁ and N-(1-deoxy-D-fructos-1-yl) FB₁ on the sphingolipid metabolism in rats.
Hahn I; Nagl V; Schwartz-Zimmermann HE; Varga E; Schwarz C; Slavik V; Reisinger N; Malachová A; Cirlini M; Generotti S; Dall'Asta C; Krska R; Moll WD; Berthiller F
Food Chem Toxicol; 2015 Feb; 76():11-8. PubMed ID: 25475052
[TBL] [Abstract][Full Text] [Related]
15. Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine.
Wang E; Riley RT; Meredith FI; Merrill AH
J Nutr; 1999 Jan; 129(1):214-20. PubMed ID: 9915902
[TBL] [Abstract][Full Text] [Related]
16. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.
Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH
J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265
[TBL] [Abstract][Full Text] [Related]
17. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material.
Shephard GS; van der Westhuizen L; Thiel PG; Gelderblom WC; Marasas WF; van Schalkwyk DJ
Toxicon; 1996 May; 34(5):527-34. PubMed ID: 8783447
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatographic determination of the sphinganine/sphingosine ratio in serum.
Shephard GS; van der Westhuizen L
J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):219-22. PubMed ID: 9686890
[TBL] [Abstract][Full Text] [Related]
19. Ineffectiveness of activated carbon in reducing the alteration of sphingolipid metabolism in rats exposed to fumonisin-contaminated diets.
Solfrizzo M; Carratu MR; Avantaggiato G; Galvano F; Pietri A; Visconti A
Food Chem Toxicol; 2001 May; 39(5):507-11. PubMed ID: 11313118
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of sphingolipids in Wistar rats treated to prolonged and single oral doses of fumonisin b₁.
Direito GM; Almeida AP; Aquino S; Alves Dos Reis T; Rodrigues Pozzi C; Corrêa B
Int J Mol Sci; 2009 Jan; 10(1):50-61. PubMed ID: 19333435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
